Lilly Nets Another 2nd Circ. Win In Zyprexa MDL
The Second Circuit on Wednesday affirmed a victory for Eli Lilly & Co. in a suit in multidistrict litigation claiming it failed to warn of diabetes risks associated with its antipsychotic...To view the full article, register now.
Already a subscriber? Click here to view full article